ELDELUMAB
UNII 15O91A27I5

Substance Identification & Data

This profile provides standardized clinical and technical data for Eldelumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 15O91A27I5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 946414-98-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
15O91A27I5
CAS Registry Number
946414-98-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ELDELUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9746
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
YY-155
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eldelumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELDELUMAB

Common Names & Synonyms

ELDELUMAB [INN]
ELDELUMAB [USAN]
ELDELUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN C-X-C MOTIF CHEMOKINE 10 (10 KDA INTERFERON GAMMA-INDUCED PROTEIN, SMALL-INDUCIBLE CYTOKINE B10))

Technical Codes

BMS-936557
MDX-1100